nach oben

Current Pulmonology Reports

Erschienen in:

27.05.2017 | Pulmonology in Combat Medicine (G Eapen, Section Editor)

Non-traumatic Pulmonary Emergencies in the Deployed Setting

verfasst von: Nikhil A. Huprikar, Steven D. Deas, Andrew J. Skabelund

Erschienen in: Current Pulmonology Reports | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Pulmonary disorders accounted for up to 8% of the over 70,000 medical evacuations conducted from Iraq and Afghanistan in the past 15 years. This review of non-traumatic pulmonary emergencies provides an overview of deployed military medical treatment capabilities and highlights pulmonary emergencies requiring aeromedical evacuation from theater.

Recent Findings

Recent studies have improved the epidemiologic evaluation of non-traumatic pulmonary disease, highlighted specific parenchymal diseases, and revealed infection pathologies unique to the deployed setting. Literature regarding possible chemical exposures in the current deployed environment remains limited.

Summary

Respiratory disorders requiring medical evacuation represent a wide variety of diseases. Complications such as pulmonary emboli, infectious pathogens, and hazardous chemical exposures threaten the deployed warfighter. Adequate medical care requires an understanding of these potential environmental exposures. This review serves as a general overview of this topic; however, more research regarding epidemiologic and environmental exposures is required.

• Crawley PG. The critical care air transport experience. Current Pulmonology Reports. 2016;5(2):77–85. This article provides an overview of critical care transport capabilities in U.S. military conflicts but also highlights the limitations of the various echelons of care both in the deployed environment and international locations.

Grathwohl KW, Venticinque SG. Organizational characteristics of the austere intensive care unit: the evolution of military trauma and critical care medicine; applications for civilian medical care systems. Crit Care Med. 2008;36(Suppl):S275–S83. doi:10.1097/CCM.0b013e31817da825.CrossRefPubMed

Venticinque SG, Grathwohl KW. Critical care in the austere environment: providing exceptional care in unusual places. Crit Care Med. 2008;36(7):S284–S92.PubMed

Cancio LC, Horvath EE, Barillo DJ, Kopchinski BJ, Charter KR, Montalvo AE, et al. Burn support for Operation Iraqi Freedom and related operations, 2003 to 2004. Journal of Burn Care & Research. 2005;26(2):151–61.

• Bein T, Zonies D, Philipp A, Zimmermann M, Osborn EC, Allan PF, et al. Transportable extracorporeal lung support for rescue of severe respiratory failure in combat casualties. J Trauma Acute Care Surg. 2012;73(6):1450–6. The article provides a brief overview of the utility of extracorporeal lung support in patients deployed internationally. PubMed

Center AFHS. Causes of medical evacuations from Operations Iraqi Freedom (OIF), New Dawn (OND) and Enduring Freedom (OEF), active and reserve components, US Armed Forces, October 2001-September 2010. MSMR. 2011;18(2):2.

Center AFHS. Medical evacuations from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF), active and reserve components, U.S. Armed Forces, October 2001-September 2009. MSMR. 2010;17(2):2–7.

Murray CK, Reynolds JC, Schroeder JM, Harrison MB, Evans OM, Hospenthal DR. Spectrum of care provided at an echelon II medical unit during Operation Iraqi Freedom. Mil Med. 2005;170(6):516–20.PubMed

Harman DR, Hooper TI, Gackstetter GD. Aeromedical evacuations from Operation Iraqi Freedom: a descriptive study. Mil Med. 2005;170(6):521–7.PubMed

10.

Lundy JB, Swift CB, McFarland CC, Mahoney LCP, Perkins RM, Holcomb JB. A descriptive analysis of patients admitted to the intensive care unit of the 10th combat support hospital deployed in Ibn Sina, Baghdad, Iraq, from October 19, 2005, to October 19, 2006. J Intensive Care Med. 2010;25(3):156–62. doi:10.1177/0885066609359588.CrossRefPubMed

11.

Center AFHS. Medical evacuations from Afghanistan during Operation Enduring Freedom, active and reserve components, U.S. Armed Forces, 7 October 2001-31 December 2012. MSMR. 2013;20(6):2–8.

12.

Maddry JK, Arana AA, Reeves LK, Perez CA, Mora AG, Savell SC, Bebarta VS. An evaluation of critically ill non-trauma patients evacuated by CCATT. Pending. Pending;In Preparation.

13.

Wojcik BE, Humphrey RJ, Czejdo B, Hassell LH. US Army disease and nonbattle injury model, refined in Afghanistan and Iraq. Mil Med. 2008;173(9):825–35.PubMed

14.

Philit F, Etienne-Mastroianni B, Parrot A, Guerin C, Robert D, Cordier JF. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med. 2002;166(9):1235–9. doi:10.1164/rccm.2112056.CrossRefPubMed

15.

Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med. 1989;321(9):569–74.PubMed

16.

Janz DR, O’Neal HRJ, Ely EW. Acute eosinophilic pneumonia: a case report and review of the literature. Crit Care Med. 2009;37(4):1470–4. doi:10.1097/CCM.0b013e31819cc502.CrossRefPubMed

17.

Thota D, Latham E. Case report of electronic cigarettes possibly associated with eosinophilic pneumonitis in a previously healthy active-duty sailor. The Journal of Emergency Medicine. 2014;47(1):15–7. doi:10.1016/j.jemermed.2013.09.034.CrossRefPubMed

18.

Ajani S, Kennedy CC. Idiopathic acute eosinophilic pneumonia: a retrospective case series and review of the literature. Respiratory Medicine Case Reports. 2013;10:43–7. doi:10.1016/j.rmcr.2013.06.005.CrossRefPubMedPubMedCentral

19.

Takeuchi A, Nelson C, Yamamoto I, Yamashiro S, Myers J. Acute eosinophilic pneumonia after resumption of cigarette smoking. Mil Med. 2016;181(6):e613–e5. doi:10.7205/MILMED-D-15-00300.CrossRefPubMed

20.

Shorr AF, Scoville SL, Cersovsky SB, et al. Acute eosinophilic pneumonia among US military personnel deployed in or near iraq. JAMA. 2004;292(24):2997–3005. doi:10.1001/jama.292.24.2997.CrossRefPubMed

21.

Force ADT. Acute respiratory distress syndrome. JAMA. 2012;307(23):2526–33.

22.

Morris MJ. Acute respiratory distress syndrome in combat casualties: military medicine and advances in mechanical ventilation. Mil Med. 2006;171(11):1039–44.PubMed

23.

Park PK, Cannon JW, Ye W, Blackbourne LH, Holcomb JB, Beninati W, et al. Incidence, risk factors, and mortality associated with acute respiratory distress syndrome in combat casualty care. J Trauma Acute Care Surg. 2016;81(5):S150–S6.PubMed

24.

•• Chalela JA, Burnett WT. Chemical terrorism for the intensivist. Mil Med. 2012;177(5):495–500. This review provides clinical aspects associated with diagnosis and treating victims of chemical attacks. PubMed

25.

Chivers CJ. The secret casualties of Iraq’s abandoned chemical weapons. New York Times. 2014. https://www.nytimes.com/interactive/2014/10/14/world/middleeast/us-casualties-of-iraq-chemical-weapons.html?_r=0.

26.

Schmitt E. ISIS used chemical weapons in Syria and Iraq at least 52 times, report says. New York Times. 2016. https://www.nytimes.com/2016/11/21/world/middleeast/isis-chemical-weapons-syria-iraq-mosul.html.

27.

Agency CI. Detailed preliminary assessment of chemical weapons findings. In: Iraq’s chemical weapons program - Annex F. 2007. https://www.cia.gov/library/resports/general-reports-1/iraq_wmd_2004/chap5_annexF.html. Accessed Dec 17 2016.

28.

Kales SN, Christiani DC. Acute chemical emergencies. N Engl J Med. 2004;350(8):800–8. doi:10.1056/NEJMra030370.CrossRefPubMed

29.

Jones R, Wills B, Kang C. Chlorine gas: an evolving hazardous material threat and unconventional weapon. Western J Emerg Med. 2010; 11(2):151–156

30.

Bosse GM. Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation. J Toxicol Clin Toxicol. 1994;32(3):233–41.PubMed

31.

Jones RN, Hughes JM, Glindmeyer H, Weill H. Lung function after acute chlorine exposure 1–3. Am Rev Respir Dis. 1986;134(6):1190–5.PubMed

32.

Maher A. Islamic State ‘using chlorine gas’ in Iraq roadside bombs. BBC. 2015. http://www.bbc.com/news/world-middle-east-31847427.

33.

Cave DF, Ahmad. Iraq militants use chlorine in 3 bombings. The New York Times. 2007. http://www.nytimes.com/2007/02/21/world/middleeast/21cnd-baghdad.html.

34.

Johnston WR. Summary of historical attacks using chemical or biological weapons. 2016. http://www.johnstonsarchive.net.

35.

Batchelor T. ISIS targets civilians with chemical weapon attack in Iraq and Syria. Express. 2015. http://www.express.co.uk/news/world/592379/Islamic-State-chemical-weapon-attack-jihaditerrorists-chlorine-rockets.

36.

Cave D, Fadam A. Iraq militants use chlorine in 3 bombings. The New York Times. 2007. http://www.nytimes.com/2007/02/21/world/middleeast/21cnd-baghdad.html.

37.

Borak J, Diller WF. Phosgene exposure: mechanisms of injury and treatment strategies. J Occup Environ Med. 2001;43(2):110–9.PubMed

38.

Parkhouse DA, Brown RF, Jugg BJ, Harban FM, Platt J, Kenward CE, et al. Protective ventilation strategies in the management of phosgene-induced acute lung injury. Mil Med. 2007;172(3):295–300.PubMed

39.

Grainge C, Rice P. Management of phosgene-induced acute lung injury. Clin Toxicol. 2010;48(6):497–508.

40.

Zierold D, Chauviere M. Hydrogen fluoride inhalation injury because of a fire suppression system. Mil Med. 2012;177(1):108–12.PubMed

41.

Registry AfTSaD. Sulfur dioxide: Center for Disease Control 2015. https://www.atsdr.cdc.gov/toxprofiles/TP.asp?id=253&tid=46.

42.

Warenycia MW, Goodwin LR, Benishin CG, Reiffenstein R, Francom DM, Taylor JD, et al. Acute hydrogen sulfide poisoning: demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels. Biochem Pharmacol. 1989;38(6):973–81.PubMed

43.

Snyder JW, Safir EF, Summerville GP, Middleberg RA. Occupational fatality and persistent neurological sequelae after mass exposure to hydrogen sulfide. Am J Emerg Med. 1995;13(2):199–203.PubMed

44.

Affairs USDoV. Sulfur fire at Mishraq State Sulfur Mine. Online 2015. https://www.publichealth.va.gov/exposures/mishraq-sulfur-fire/index.asp.

45.

U.S. Army Public Health Command EMP. Health assessment of 2003 Al Mishraq sulfur fire incident. In: USAPHC, editor. Online 2012.

46.

King MS, Eisenberg R, Newman JH, Tolle JJ, Harrell Jr FE, Nian H, et al. Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan. N Engl J Med. 2011;365(3):222–30.PubMedPubMedCentral

47.

BBC. Mosul battle: hundreds treated over toxic fumes in Iraq. BBC. 2016. http://www.bbc.com/news/world-middle-east-37738667.

48.

Goverman J, Montecino R, Ibrahim A, Sarhane KA, Tompkins RG, Fagan SP. Sulfur mustard gas exposure: case report and review of the literature. Annals of Burns and Fire Disasters. 2014;27(3):146–50.PubMedPubMedCentral

49.

Phippen JW. A mustard gas attack on U.S. troop: a general confirmed that Islamic State fighters used the chemical weapon this week in an attack on American soldiers in Iraq. The Atlantic. 2016.

50.

Michaels J. Pentagon confirms ISIL tried to use mustard gas on U.S. troops. USA Today. 2016.

51.

Brown M. Military chemical warfare agent human subjects testing: part 2-long-term health effects among participants of US military chemical warfare agent testing. Mil Med. 2009;174(10):1049–54.PubMed

52.

Cosar A, Kenar L. An anesthesiological approach to nerve agent victims. Mil Med. 2006;171(1):7–11.PubMed

53.

Proctor SP, Heaton KJ, Heeren T, White RF. Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans. Neurotoxicology. 2006;27(6):931–9. doi:10.1016/j.neuro.2006.08.001.CrossRefPubMed

54.

Charbonneau LN, Michelle. U.N. confirms sarin used in Syria attack; U.S., UK, France blame Assad. Reuters. 2013.

55.

Boyer NL, Forbes DA, Chung KK. Practical management of burns and inhalation injury. Current Pulmonology Reports. 2016;5(2):63–9.

56.

• Walker PF, Buehner MF, Wood LA, Boyer NL, Driscoll IR, Lundy JB, et al. Diagnosis and management of inhalation injury: an updated review. Crit Care. 2015;19(1):1. Review of recent advances in diagnosis and treatment of inhalation injuries

57.

Kwon HP, Zanders TB, Regn DD, Burkett SE, Ward JA, Nguyen R, et al. Comparison of virtual bronchoscopy to fiber-optic bronchoscopy for assessment of inhalation injury severity. Burns. 2014;40(7):1308–15. doi:10.1016/j.burns.2014.06.007.CrossRefPubMed

58.

Ennis JL, Chung KK, Renz EM, Barillo DJ, Albrecht MC, Jones JA, et al. Joint Theater Trauma System implementation of burn resuscitation guidelines improves outcomes in severely burned military casualties. J Trauma Acute Care Surg. 2008;64(2):S146–S52.

59.

Mlcak RP, Suman OE, Herndon DN. Respiratory management of inhalation injury. Burns. 2007;33(1):2–13.PubMed

60.

Carr JA, Phillips BD, Bowling WM. The utility of bronchoscopy after inhalation injury complicated by pneumonia in burn patients: results from the National Burn Repository. Journal of Burn Care & Research. 2009;30(6):967–74.

61.

Kauvar DS, Wolf SE, Wade CE, Cancio LC, Renz EM, Holcomb JB. Burns sustained in combat explosions in Operations Iraqi and Enduring Freedom (OIF/OEF explosion burns). Burns. 2006;32(7):853–7.PubMed

62.

Brooks SM, Weiss MA, Bernstein I. Reactive airways dysfunction syndrome (RADS): persistent asthma syndrome after high level irritant exposures. Chest. 1985;88(3):376–84.PubMed

63.

White CW, Martin JG. Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models. Proc Am Thorac Soc. 2010;7(4):257–63.PubMedPubMedCentral

64.

Alberts WM, Guillermo A. Reactive airways dysfunction syndrome. CHEST Journal. 1996;109(6):1618–26.

65.

Bardana EJ. Reactive airways dysfunction syndrome (RADS): guidelines for diagnosis and treatment and insight into likely prognosis. Annals of Allergy, Asthma & Immunology. 1999;83(6):583–6.

66.

Regulation A. Standards of medical fitness. Headquarters, Department of the Army Washington, DC; 2004.

67.

Roop SA, Niven AS, Calvin BE, Bader J, Zacher LL. The prevalence and impact of respiratory symptoms in asthmatics and nonasthmatics during deployment. Mil Med. 2007;172(12):1264–9.PubMed

68.

Szema AM, Peters MC, Weissinger KM, Gagliano CA, Chen JJ, editors. New-onset asthma among soldiers serving in Iraq and Afghanistan. Allergy and Asthma Proceedings; 2010: OceanSide Publications, Inc.

69.

Smith B, Wong CA, Boyko EJ, Phillips CJ, Gackstetter GD, Ryan MAK, et al. The effects of exposure to documented open-air burn pits on respiratory health among deployers of the Millennium Cohort Study. J Occup Environ Med. 2012;54(6):708–16. doi:10.1097/JOM.0b013e31825107f9.CrossRefPubMed

70.

Smith B, Wong CA, Smith TC, Boyko EJ, Gackstetter GD. Newly reported respiratory symptoms and conditions among military personnel deployed to Iraq and Afghanistan: a prospective population-based study. Am J Epidemiol. 2009;170(11):1433–42.PubMed

71.

Center AFHS. Deployment-related conditions of special surveillance interest, U.S. Armed Forces, by month and service, January 2003 - October 2009 MSMR. 2009; 16(11):16–9.

72.

Hartzell JD, Gleeson T, Scoville S, Massung RF, Wortmann G, Martin GJ. Practice guidelines for the diagnosis and management of patients with Q fever by the Armed Forces Infectious Diseases Society. Mil Med. 2012;177(5):484–94.PubMed

73.

Wallace MR, Hale BR, Utz GC, Olson PE, Earhart KC, Thornton SA, et al. Endemic infectious diseases of Afghanistan. Clin Infect Dis. 2002;34(Supplement 5):S171–207. doi:10.1086/340704.CrossRefPubMed

74.

Faix DJ, Harrison DJ, Riddle MS, Vaughn AF, Yingst SL, Earhart K, et al. Outbreak of Q fever among US military in western Iraq, June–July 2005. Clin Infect Dis. 2008;46(7):e65–e8. doi:10.1086/528866.CrossRefPubMed

75.

Hartzell JD, Peng SW, Wood-Morris RN, Sarmiento DM, Collen JF, Robben PM, et al. Atypical Q fever in US soldiers. Emerg Infect Dis. 2007;13(8):1247.PubMedPubMedCentral

76.

Anderson AD, Baker TR, Littrell AC, Mott RL, Niebuhr DW, Smoak BL. Seroepidemiologic survey for Coxiella burnetii among hospitalized US troops deployed to Iraq*. Zoonoses Public Health. 2011;58(4):276–83. doi:10.1111/j.1863-2378.2010.01347.x.CrossRefPubMed

77.

• Eick AA, Faix DJ, Tobler SK, Nevin RL, Lindler LE, Hu Z, et al. Serosurvey of bacterial and viral respiratory pathogens among deployed US service members. American Journal of Preventive Medicine. 2011;41(6):573–80. An evaluation of respiratory pathologies responsible for infections in soldiers from 2004 to 2009. This article provides insights regarding potential infectious exposure agents in the deployed environment. PubMed

78.

Center AFHS. Preliminary report: investigation and control of novel H1N1 influenza among soldiers of the Afghan National Army, Kabul, Afghanistan, 30 October - 14 November 2009. MSMR. 2009;16(11):8–11.

79.

Conger NG, Paolino KM, Osborn EC, Rusnak JM, Günther S, Pool J, et al. Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009. Emerging Infectious Disease journal. 2015;21(1):23. doi:10.3201/eid2101.141413.CrossRef

80.

Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358(12):1271–81. doi:10.1056/NEJMra070741.CrossRefPubMed

81.

Yun HC, Weintrob AC, Conger NG, Li P, Lu D, Tribble DR, et al. Healthcare-associated pneumonia among U.S. combat casualties, 2009 to 2010. Mil Med. 2015;180(1):104–10. doi:10.7205/MILMED-D-14-00209.CrossRefPubMedPubMedCentral

82.

Murray CK, Hospenthal DR. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis. 2005;18(6):502–6.PubMed

83.

Eliopoulos GM, Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254–63. doi:10.1086/529198.CrossRef

Titel: Non-traumatic Pulmonary Emergencies in the Deployed Setting
verfasst von: Nikhil A. Huprikar
Steven D. Deas
Andrew J. Skabelund
Publikationsdatum: 27.05.2017
Verlag: Springer US
Erschienen in: Current Pulmonology Reports / Ausgabe 2/2017
Elektronische ISSN: 2199-2428
DOI: https://doi.org/10.1007/s13665-017-0180-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Hypoventilation Syndromes

Sleep-Related Breathing Disorders and Cancer

Impact of High Altitude on Military Operations

Screening Programs for Obstructive Sleep Apnea

Overlap Syndrome